Telix Pharmaceuticals Ltd. (AU:TLX) has released an update.
Telix Pharmaceuticals has begun trading its American Depository Shares on the Nasdaq Global Select Market under the symbol ‘TLX’, marking a significant step in its growth strategy. This move is expected to enhance access to Telix’s shares for U.S. and global investors, aligning with the company’s expanding presence in North America. With its primary listing remaining on the ASX, Telix aims to bolster its leadership in the radiopharmaceuticals sector.
For further insights into AU:TLX stock, check out TipRanks’ Stock Analysis page.
Trending Articles
- Paramount Global (NASDAQ:PARA) Gains From Yellowstone in Europe
- Ford (NYSE:F) Shares Slip After Huge Fine
- Intel (NASDAQ:INTC) Notches Up despite New Loss to AMD Processors
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
